Practice Management

According to this expert, honesty is the best policy – especially when appealing to insurance carriers on behalf of your patients.

Dr. Missy Clifton shares best practices on launching and managing an online cosmeceutical store that is convenient for patients and keeps them coming back for more.

Most dermatologists train in a clinical setting that accepts underinsured patients, but only some physicians continue along this path. Elaine Siegfried, M.D. offers her point of view on the pros and cons of working with this population, and discusses how to maintain a socioeconomically inclusive dermatology practice.

If you want to get paid promptly in 2019, don't get too comfortable with biopsy codes you've been using for years, says Alexander Miller, M.D., F.A.A.D. Read more from his presentation on coding and office management from the American Academy of Dermatology Annual Meeting in Washington, D.C.

As an expert on coding and office management, Mark D. Kaufmann, M.D., explained important role the AMA's Specialty Society Relative Value Update Committee (RUC) plays in code valuation during his presentation at the American Academy of Dermatology Annual Meeting in Washington, D.C.

In order for a dermatology practice to advance to the next financial level, it is important to identify needed areas of improvement. This is where benchmarking comes into play.

Although prescribers who provide in-office dispensing must satisfy applicable state and other requirements, a recent ruling against Allergan's attempt to shut down Prescriber's Choice appears to pave the way for expansion of these services, according to Wm. Philip Werschler, M.D.

Dermatology nurse practitioners (NPs) faced pressing challenges in 2018, including a misperception of their role and scope of practice and a lack of established competencies needed in the specialty. According to one expert, many of these issues will be remedied in 2019. Participate in this forum.

Medical practice consultant Debra Phairas offers advice for physicians who are trying to implement practice change.

Novel therapeutic recently completed phase three CAMP-1 and CAMP-2 pivotal trials, demonstrating statistically significant improvements in patients with molluscum contagiosum.

Industry relationships are essential for innovation in dermatology. In this month's column, Steve Xu, M.D., and Michael L. Sierra, Ph.D., provide their insight on collaborating with industry.

What can you do if a patient slanders your reputation on social media? David J. Goldberg, M.D.,  J.D., provides his insight in this month's Legal Eagle column. 

Marketing experts say that it’s worth it for aesthetic physicians to maximize their RealSelf profiles, and to do so takes relatively simple steps.

It puts Botox (and more) on a monthly budget - Is a spa subscription model right for your practice?

In this table, we highlight some of the forthcoming changes to the Medicare Physician Fee Schedule (PFS) from the Centers for Medicare & Medicaid Services (CMS).

Outpatient dermatology services can be available to any patient. However, according to recent research, that doesn’t mean all patients access or take advantage of this clinical care in the same way.

Robot dermatologists aren’t yet seeing patients for routine care, but artificial intelligence (AI) and other technology tools are growing in popularity throughout the industry. Learn more about how these advances in technology are impacting practices.

Artificial intelligence (AI) tools are steadily growing in popularity throughout medicine, particularly in dermatology. But does AI pose a threat to dermatologists? Find out in this article.

Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.

What exactly is digital health? Dr. Steve Xu tackles this question in this month's Innovation column.

In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs.

Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.

Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG). 

The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.

The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.